| Literature DB >> 34135965 |
Farah Chouchene1,2, Fatma Masmoudi1,2, Ahlem Baaziz1,2, Fethi Maatouk1,2, Hichem Ghedira1,2.
Abstract
OBJECTIVE: To compare the effectiveness of topical antibiotic mixtures used in noninstrumental endodontic treatment (NIET) of primary teeth.Entities:
Year: 2021 PMID: 34135965 PMCID: PMC8175181 DOI: 10.1155/2021/5518599
Source DB: PubMed Journal: Int J Dent ISSN: 1687-8728
Keywords used to develop the search strategies.
| Database | Keywords |
|
|---|---|---|
| PubMed | ((“Dental pulp Necrosis”[Mesh]) AND “anti-bacterial Agents”[Mesh]) AND “tooth, Deciduous”[Mesh] ((“tooth, Deciduous”[Mesh]) AND “root canal Therapy”[Mesh]) AND “anti-bacterial Agents”[Mesh] ((“anti-bacterial Agents”[Mesh]) AND “tooth, Deciduous”[Mesh] ((“anti-bacterial Agents”[Mesh]) AND “root canal Preparation”[Mesh]) AND “tooth, Deciduous”[Mesh] ((“root canal Therapy”[Mesh]) OR “root canal preparation”[Mesh]) AND “anti-bacterial Agents”[Mesh] AND “tooth, Deciduous”[Mesh] ((“Metronidazole”[Mesh]) OR “Ciprofloxacin”[Mesh]) AND “Minocycline”[Mesh]) AND “Tinidazole”[Mesh]) AND “Tetracycline”[Mesh]) AND “Ornidazole”[Mesh]) AND “Clindamycin”[Mesh]) OR “anti-bacterial Agents”[Mesh]) AND (“root canal Preparation”[Mesh] OR “root canal Therapy”[Mesh])) AND “tooth, Deciduous”[Mesh] | 2343 |
|
| ||
| Cochrane Library | “#1 dental pulp necrosis” | 97 |
| “#2 anti-bacterial agents” | ||
| “#3 root canal therapy” | ||
| “#4 root canal preparation” | ||
| “#5 deciduous tooth” | ||
| “#6-#1 AND #2 AND #3” | ||
| “#7-#6 AND #3 AND #2” | ||
| “#8-#5 AND #2 AND #6” | ||
| “#9-#2 AND #4 AND #6” | ||
| “#10-#3 OR #3 AND #2 AND #6” | ||
| “#11 metronidazole” | ||
| “#12 ciprofloxacin” | ||
| “#13 minocycline” | ||
| “#14 tinidazole” | ||
| “#15 tetracycline” | ||
| “#16 ornidazole” | ||
| “#17 clindamycin” | ||
| “#18 agent antimycobacterial” | ||
| “#19 antibiotic” | ||
| “#21 antibiotic paste” | ||
| “#22 non-instrumentation endodontic” | ||
| “#23 lstr” | ||
| “#24 root canal treatment” | ||
| “#25-#12 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20 OR #21 AND #5 AND #6” | ||
| “#26-#5 OR #3 OR #4 OR #22 OR #23 OR #24 AND #6” | ||
|
| ||
| Scopus | TITLE-ABS-KEY (“Dental pulp Necrosis” AND “Anti-Bacterial Agents” AND “Tooth, Deciduous”) | 765 |
| TITLE-ABS-KEY (“tooth, deciduous” AND “root canal therapy” AND “anti-bacterial agents”) | ||
| TITLE-ABS-KEY (” anti-bacterial agents” AND “tooth, deciduous”) | ||
| TITLE-ABS-KEY (“anti-bacterial agents” AND “root canal preparation” AND “tooth, deciduous”) | ||
| TITLE-ABS-KEY (“root canal therapy” OR “root canal preparation” AND “anti-bacterial agents” AND “tooth, deciduous”) | ||
| TITLE-ABS-KEY (“metronidazole” OR “ciprofloxacin” OR “minocycline” OR “tinidazole” “tetracycline” OR “agents anti-bacterial” OR “agentsantibacterial” OR “agentsantimycobacterial” OR “antibiotic” OR “antibiotic paste” AND “deciduous teeth”) | ||
| TITLE-ABS-KEY (“root canal preparation” OR “canal preparation root” OR “root canal therapy” OR “canal therapies root” OR “root canal procedures” OR “root canal treatment” OR “lstr” OR “non-instrumentation endodontic” AND “deciduous teeth”) | ||
Figure 1Prisma flow diagram.
Figure 2Risk-of bias summary (green indicates low risk of bias and yellow indicates some concerns of bias).
Characteristics of the included studies.
| Study | Study design | Subjects (no. of children/age in years/no. of teeth) | Primary teeth selected | Results | Conclusions | |||
|---|---|---|---|---|---|---|---|---|
| Antibiotics mixture | Follow-up (months) | Clinical success | Radiograph success | |||||
| Pinky et al. [ | RCT | 28 children/4–10 years/40 primary teeth | Primary molars | Ciprofloxacin-minocycline-metronidazole | 3 | 20/20 (100) | 20/20 (100) | Good clinical and radiographic success in both groups. |
| Ciprofloxacin-minocycline-ornidazole | 20/20 (100) | 20/20 (100) | ||||||
|
| ||||||||
| Nanda et al. [ | RCT | 38 children/4–10 years/40 primary teeth | Primary molars | Ciprofloxacin-minocycline-metronidazole | 3 | 20/20 (100) | 20/20 (100) | 100% clinical success in both groups. |
| Ciprofloxacin-minocycline-ornidazole | 20/20 (100) | 20/20 (100) | ||||||
|
| ||||||||
| Singh et al. [ | RCT | 38 children/5–10 years/80 primary teeth | Primary teeth | Ciprofloxacin-metronidazole-minocycline | 3 | 40/40 (100) | Nm Nm | No statistically significant difference between both groups. |
| Ciprofloxacin-minocycline-ornidazole | 40/40 (100) | Nm Nm | ||||||
|
| ||||||||
| Jaya et al. [ | RCT | 25 children/6–9 years/30 primary teeth | Primary molars | Ciprofloxacin-metronidazole-minocycline | 6 | 15/15 (100) | 9/15 (60) | Good clinical and radiographic success in both groups. |
| Ciprofloxacin-tinidazole-minocycline | 15/15 (100) | 8/15 (53.3) | ||||||
|
| ||||||||
| Raslan et al. [ | RCT | 22 children/Nm/42 primary teeth | Mandibular primary molars | Ciprofloxacin-metronidazole-minocycline | 1 | 21/21 (100) | 21/21 (100) | No statistically significant differences |
| Ciprofloxacin-metronidazole-clindamycin | 21/21 (100) | 21/21 (100) | ||||||
RCT: randomized controlled study; Nm: not mentioned.
Summary of the results drawn from selected studies at the 12-month follow-up.
| Study | ATB mixture | Vehicle | Ratio | Irrigants | Restoration | Final follow-up (months) | Clinical outcomes | Exfoliation | Radiographical outcomes | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pain | Swelling/fistula | Abscess | Pain in percussion | Mobility | Bone regeneration | Increased radiolucency | No changes | ||||||||
| Pinky et al. [ | Ciprofloxacin-metronidazole-minocycline | Propylene glycol | 1 : 3 : 3 | Saline | Temporary dressing with zinc oxide eugenol/stainless steel crowns (after 30 days) | 12 | 2 (10%) | — | — | — | — | — | 11 (55%) | 2 (10%) | 7 (35%) |
| Ciprofloxacin-minocycline-ornidazole | 1 : 3 : 3 | — | — | — | — | — | — | 12 (60%) | — | 8 (40%) | |||||
| Nanda et al. [ | Ciprofloxacin-metronidazole-minocycline | Propylene glycol | 1 : 3 : 3 | Saline | Glass ionomer cement/stainless steel crowns (at the same visit) | 12 | — | — | — | — | — | — | 6 (30%) | 3 (15%) | 7 (35%) |
| Ciprofloxacin-minocycline-ornidazole | 1 : 3 : 3 | — | — | — | — | — | 7 (35%) | 4 (20%) | 1 (5%) | ||||||
| Singh et al. [ | Ciprofloxacin-metronidazole-minocycline | Propylene glycol | 1 : 3 : 3 | Saline | Temporary dressing (zinc oxide eugenol/glass ionomer cement (after 15 days)/stainless steel crowns (after 30 days)) | 12 | 2 (5%) | — | — | — | 2 (5%) | — | 22 (55%) | 4 (10%) | 14 (35%) |
| Ciprofloxacin-minocycline-ornidazole | 1 : 3 : 3 | — | — | — | — | — | 24 (60%) | — | 16 (14%) | ||||||
| Jaya et al. [ | Ciprofloxacin-metronidazole-minocycline | Propylene glycol/macrogol | 1 : 3 : 3 | Saline | Glass ionomer cement/stainless steel crowns (at the same visit) | 24 | — | — | — | — | 8 (62%). | — | Nm | 9 (69%). | Nm |
| Ciprofloxacin-tinidazole-minocycline | 1 : 3 : 3 | — | — | — | — | 7 (50%) | Nm | 8 (57%) | Nm | ||||||
| Raslan et al. [ | Ciprofloxacin-metronidazole-minocycline | Propylene glycol | 1 : 1 : 1 | Phosphoric acid/sterile water | Glass ionomer cement/stainless steel crowns (at the same visit) | 12 | — | 1 (3, 6%) | 2 (9, 52%) | — | — | 3 (16.67%) | 11 (61.11%) | 1 (5.56%) | 3 (16.67) |
| Ciprofloxacin-metronidazole-clindamycin | 1 : 1 : 1 | — | — | 1 (3, 52%) | — | — | 2 (10%) | 11 (55%) | 4 (20%) | 3 (15%) | |||||
The symbol “—” indicates absent; Nm: not mentioned.